Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$4.2M
-39.2% from 2023
Prescriptions
11K
$386.04 per claim
Patients
1,543
1,547 prescribers
Total spending, 2024
$4.2M
$2,726.90 per patient
Medicare prescription drug plans paid $4.2M for Efavirenz in 2024, for 10,898 prescriptions and refills to 1,543 patients (down 39.2% from 2023). The average cost per claim was $386.04.
New York had the highest Medicare cost for Efavirenz in 2024: $631K for 1,480 claims, followed by California ($536K).
Yuliya Nudelman, internal medicine in Lakewood, NJ, had the highest Medicare cost for Efavirenz in 2024: 97 claims costing $34K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Yuliya Nudelman Lakewood, NJ | Internal Medicine | 97 | Under 11 | $34K |
| Bruce Hirsch Manhasset, NY | Infectious Disease | 42 | Under 11 | $25K |
| Peter L Alpert |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,954 | 14,491 | 2,040 | $8.0M |
| 2023 | 1,759 | 12,645 | 1,779 | $6.9M |
| 2024 | 1,547 | 10,898 | 1,543 | $4.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 73 |
| Under 11 |
| $24K |
| Mark Condoluci Voorhees, NJ | Infectious Disease | 52 | Under 11 | $24K |
| Robert Sullivan Altoona, PA | Internal Medicine | 29 | Under 11 | $21K |
| Karen F Brudney New York, NY | Internal Medicine | 95 | Under 11 | $21K |
| David H Chansolme Oklahoma City, OK | Infectious Disease | 29 | Under 11 | $20K |
| David M Rowles Richmond, VA | Infectious Disease | 23 | Under 11 | $20K |
| John P Doweiko Boston, MA | Internal Medicine | 22 | Under 11 | $19K |
| Michael Lawlor Hartford, CT | Infectious Disease | 28 | Under 11 | $19K |
| William J Lewis Tulsa, OK | Infectious Disease | 29 | Under 11 | $19K |
| Ann E Stapleton Palm Springs, CA | Internal Medicine | 37 | Under 11 | $18K |
| Mark B Carr Nashville, TN | Infectious Disease | 19 | Under 11 | $17K |
| Shubha J Kerkar Palm Springs, CA | Internal Medicine | 15 | Under 11 | $17K |
| Samuel T Merrick New York, NY | Internal Medicine | 45 | Under 11 | $16K |
| Marina I Guzman Coram, NY | Nurse Practitioner | 13 | Under 11 | $15K |
| Mary J Hopkins Boston, MA | Infectious Disease | 13 | Under 11 | $15K |
| Fernando Alemany Opelousas, LA | Internal Medicine | 16 | Under 11 | $15K |
| David A Olson Oakdale, CA | Internal Medicine | 49 | Under 11 | $15K |
| Ethan T Dungan Birmingham, AL | Nurse Practitioner | 59 | Under 11 | $15K |
| Ronald L Lombard Peoria, IL | Nurse Practitioner | 19 | Under 11 | $15K |
| Jeannette Ouyang-Latimer Katy, TX | Infectious Disease | 27 | Under 11 | $15K |
| Joshua B Wolfsohn Camarillo, CA | Infectious Disease | 21 | Under 11 | $14K |
| Michael T Charney San Jose, CA | Infectious Disease | 16 | Under 11 | $14K |
| Steven Johnson Aurora, CO | Infectious Disease | 50 | Under 11 | $14K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Camber Pharmace | 3,524 | $1.6M |
| Aurobindo Pharm AUROPHARMA.NS | 4,098 | $1.5M |
| Cipla USA, Inc. CIPLA.NS | 2,608 | $893K |
| Strides Pharma STAR.NS | 575 | $166K |
| Rising Pharm | 101 | $63K |